The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1/2 study of tiragolumab and atezolizumab in patients with relapsed or refractory SMARCB1 or SMARCA4 deficient tumors.
 
Mary Frances Wedekind
No Relationships to Disclose
 
Srivandana Akshintala
No Relationships to Disclose
 
Brigitte C. Widemann
No Relationships to Disclose
 
Charles G. Minard
Other Relationship - CHEST Journal
 
Olga Militano
No Relationships to Disclose
 
David Hall
No Relationships to Disclose
 
Zanette Bradley
No Relationships to Disclose
 
Joel M. Reid
Consulting or Advisory Role - Elucida Oncology
 
Joseph Gerald Pressey
Honoraria - CSRA
 
Elad Sharon
No Relationships to Disclose
 
Elizabeth Fox
No Relationships to Disclose
 
Brenda Weigel
No Relationships to Disclose